We're making updates and relaunching soon. Get notified

Straight answers about GLP-1 medications

Plain-language guides on dosing, side effects, costs, and what to look for in a provider.

Relaunching Soon

  • Relaunching as an independent GLP-1 guide
  • Get notified when we relaunch
  • We only ask for your email
Get Started

One email to confirm. Unsubscribe anytime.

ICD-10 Codes for GLP-1 Prior Authorization: E66 and Z68 List

You’ve spent months working with your provider to get prior authorization for GLP-1 medication. Your charts are documented. You meet the BMI threshold. You’ve compiled everything your insurance company asked for. And then the request comes back, “Insufficient documentation.”

What went wrong?

Often, the problem isn’t what was documented. It’s how it was coded.

When your provider submits a prior authorization request or a claim to your insurance company, they don’t just describe your situation. They use a standardized coding system called ICD-10-CM (the U.S. clinical version of ICD-10)[1]. These codes tell the insurance company exactly what conditions are being treated, which specific diagnoses support the medical necessity, and whether you meet their clinical criteria for approval.

For GLP-1 weight management medications, the ICD-10 codes your provider includes can affect whether your insurance covers the medication or says no.

This page walks you through the main obesity and BMI codes, explains how they work together in a GLP-1 prior authorization request, and shows you which comorbidity codes can support your case. Codes on this page are from the FY 2027 ICD-10-CM code set, which took effect October 1, 2026[1]. If you’re navigating the insurance process yourself or want to understand what your provider should be documenting, this reference can help you ask the right questions.

Primary obesity codes (E66 category)

The E66 category (“Overweight and obesity”) is the main classification for obesity in ICD-10-CM[2]. Each code under E66 describes a different type or severity of obesity. The official code titles do not list BMI ranges; the BMI itself is documented with a Z68 code.

CodeDescriptionDetails
E66Overweight and obesity (category)Header only; a more specific code is used on claims
E66.0Obesity due to excess calories (subcategory)Header for E66.01 and E66.09
E66.01Morbid (severe) obesity due to excess caloriesCommonly used when severe obesity is documented (NIH defines severe obesity as BMI 40 or higher[4]); frequently seen in GLP-1 PA requests
E66.09Other obesity due to excess caloriesCommonly used for obesity due to excess calories that is not documented as severe
E66.1Drug-induced obesityObesity caused by medications (corticosteroids, antipsychotics, etc.)
E66.2Morbid (severe) obesity with alveolar hypoventilationIncludes obesity hypoventilation syndrome (Pickwickian syndrome)
E66.3OverweightSee the overweight section below
E66.811Obesity, class 1Obesity class codes added October 1, 2024 (FY 2025)
E66.812Obesity, class 2Obesity class code
E66.813Obesity, class 3Obesity class code
E66.89Other obesity not elsewhere classifiedReplaced the old E66.8 as a billable code in FY 2025 (E66.8 is now a header)
E66.9Obesity, unspecifiedIncludes “obesity NOS”; used when the type is not documented

What this means for your prior authorization:

E66.01 (morbid obesity due to excess calories) is a code often seen in GLP-1 prior authorization submissions, and some plans’ criteria may reference the newer obesity class codes. Which code applies depends on what your provider documents. The obesity code alone doesn’t tell the insurance company your specific BMI. The ICD-10-CM tabular list instructs coders to use an additional Z68 code to identify BMI, if known[2], which is why the Z68 code (described below) is usually paired with it.

Overweight codes

If your BMI falls between 25.0 and 29.9, you are classified as overweight rather than obese. This is coded separately:

CodeDescription
E66.3Overweight (NIH defines adult overweight as BMI 25 to 29.9[4])

Overweight codes are used when BMI does not meet the obesity threshold. For GLP-1 medications, an overweight code alone would not typically support a prior authorization request unless the plan’s criteria for a weight-related condition are also met. That’s why documenting your actual BMI (via the Z68 code) matters.

BMI documentation codes (Z68 series)

The Z68 series provides specific BMI range codes[2]. Adult codes apply to people 20 and older; pediatric BMI codes (Z68.5x) cover ages 2 to 19. These are supplemental codes, not primary diagnoses, but many plans look for them in a prior authorization. Insurance companies use them to check that a patient meets the BMI threshold in their coverage policy.

When a prior authorization is submitted, your provider will typically include both a primary obesity code (E66.x) and a corresponding BMI code from the Z68 series.

BMI codes 19 to 29 (normal to overweight range)

CodeBMI RangeCategory
Z68.18BMI 18.4 or less, adultUnderweight (new code October 1, 2026; Z68.1 is now a header)[3]
Z68.19BMI 18.5-19.9, adultHealthy weight range (new code October 1, 2026)
Z68.20-Z68.24BMI 20.0-24.9, adult (one code per whole BMI point)Healthy weight range; not relevant to GLP-1 PA
Z68.25-Z68.29BMI 25.0-29.9, adult (one code per whole BMI point)Overweight range; Z68.27 to Z68.29 (BMI 27.0 to 29.9) can matter when a plan accepts a lower BMI with a weight-related condition

BMI codes 30 to 39 (obesity range)

CodeBMI Range
Z68.30BMI 30-30.9
Z68.31BMI 31-31.9
Z68.32BMI 32-32.9
Z68.33BMI 33-33.9
Z68.34BMI 34-34.9
Z68.35BMI 35-35.9
Z68.36BMI 36-36.9
Z68.37BMI 37-37.9
Z68.38BMI 38-38.9
Z68.39BMI 39-39.9

BMI codes 40 and above (severe/morbid obesity range)

CodeBMI Range
Z68.41BMI 40-44.9
Z68.42BMI 45-49.9
Z68.43BMI 50-59.9
Z68.44BMI 60-69.9
Z68.45BMI 70 or greater

Why BMI codes matter for GLP-1 prior authorization:

Plans that cover GLP-1 medications for weight management commonly require a documented BMI of 30 or higher, or 27 or higher with at least one weight-related condition. Criteria vary by plan and change over time (checked October 2026), so read your plan’s own prior authorization criteria. The Z68 code documents the BMI. Without it, a prior authorization request may lack the evidence a reviewer looks for, even if the medical records show the BMI.

Think of it this way. The E66.x code says “this patient has obesity.” The Z68 code says “specifically, this patient’s BMI is in the 38.0 to 38.9 range.” Many insurers look for both pieces of information before approving coverage.

Comorbidity codes that strengthen GLP-1 prior authorization

If your BMI is between 27 and 29.9 (above normal but below the standard 30 threshold), or if you have significant weight-related health conditions, including comorbidity codes alongside your obesity and BMI codes can support a prior authorization request.

These are comorbidities that are commonly documented:

CodeConditionWhy It Matters for GLP-1
I10Essential (primary) hypertensionOne of the most common weight-related comorbidities; strengthens PA for lower BMI patients
E11.xType 2 diabetes mellitus (various subtypes)Strong indicator of metabolic dysfunction; frequently documented with GLP-1 requests
E78.xDisorders of lipoprotein metabolism and other lipidemias (for example, E78.5 hyperlipidemia, unspecified)Reflects cardiovascular risk; often paired with obesity
I25.10Atherosclerotic heart disease of native coronary artery without angina pectorisIndicates established cardiovascular disease; may support medical necessity under some plans’ criteria
G47.33Obstructive sleep apnea (adult) (pediatric)Closely linked to obesity; a common weight-related condition
E11.65Type 2 diabetes with hyperglycemiaMore specific than general diabetes code; documents glycemic control issues
K76.0Fatty (change of) liver, not elsewhere classifiedIncludes MASLD (formerly called NAFLD); obesity-related metabolic marker

How comorbidities support your prior authorization:

If you have one or more of these conditions documented in your medical records, ask your provider whether the corresponding ICD-10 codes are included in the prior authorization submission. Insurance companies use these to judge whether the patient’s weight is linked to specific health risks.

For example, a patient with a BMI of 27.8 might not meet a plan’s criteria based on BMI alone. With documented type 2 diabetes and its code (E11.x) included, the request may meet the plan’s “BMI 27 or higher with a weight-related condition” criterion. Whether it does depends on the plan.

How your provider uses these codes in prior authorization

When you complete an intake form with a new provider, you’re providing the raw information. Your provider translates that information into ICD-10 codes, which then go into the prior authorization request to your insurance company.

Here’s the process:

Step 1: Documentation

During your appointment or intake, your provider documents your current diagnoses, BMI, and any relevant health conditions. They review your medical history and confirm which codes apply to you.

Step 2: Code selection

Your provider selects the appropriate ICD-10 codes:

  • Primary diagnosis code (E66.x for obesity or E66.3 for overweight)
  • BMI documentation code (Z68.x matching your specific BMI range)
  • Any relevant comorbidity codes (I10 for hypertension, E11.x for diabetes, etc.)

Step 3: Prior authorization submission

All of these codes are included in the prior authorization request submitted to your insurance company. The insurance company uses the codes to verify that you meet their clinical criteria.

Step 4: Insurance decision

The insurance company reviews the request and determines coverage. If the prior authorization is denied, a missing code is one possible reason. One gap to rule out: an obesity code (E66.x) submitted without a BMI code (Z68.x), which can leave the reviewer without documentation that you meet the BMI threshold.

What this means for you:

If you’re going through prior authorization, make sure your recent appointment notes include documentation of your BMI. When your provider submits the prior authorization, ask them to confirm that both the obesity code and the BMI code are included. If the request is initially denied, ask specifically whether the denial cites “insufficient documentation” of BMI. If so, a resubmission with the Z68 code and the supporting chart notes may resolve it. If the denial cites something else, our guide to what to do when insurance denies your GLP-1 request walks through the appeal options.

The cash-pay alternative: no prior authorization, no codes needed

If the prior authorization process feels like too much back-and-forth, or your plan does not cover GLP-1 medications for weight management, paying out of pocket is another route.

With cash-pay GLP-1 telehealth programs, there is no prior authorization and no insurance claim to code. A prescription is still required. At most telehealth programs, a licensed provider reviews your health history and decides whether a prescription is appropriate, often using BMI and health-history criteria like those in our GLP-1 eligibility guide.

Programs differ in what they prescribe and what they charge. If you are comparing them, check:

  • Brand-name or compounded? Some programs prescribe FDA-approved brand-name medications. Others prescribe compounded GLP-1 medication, such as compounded semaglutide or tirzepatide. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products.
  • What is the total cost? Prices vary by program and dose. Compare the total cost: medication, dose increases, visits, labs, shipping, membership fees, and cancellation terms.
  • Are labs included or billed separately? Some programs include labs; others bill separately or ask you to get them through your own provider.

Transformation Health does not accept payment from providers. How we make money.

The tradeoff is that you pay out of pocket instead of using insurance. Whether that is worth it depends on your plan’s coverage, your budget, and the total cost of the program you choose.

Citations

[1] Centers for Medicare & Medicaid Services. “ICD-10 Codes” (2027 ICD-10-CM files; use for patient encounters from October 1, 2026 through September 30, 2027). Accessed October 16, 2026. https://www.cms.gov/medicare/coding-billing/icd-10-codes

[2] Centers for Medicare & Medicaid Services and CDC National Center for Health Statistics. “2027 ICD-10-CM Code Tables, Tabular and Index” (categories E66 and Z68, with code-level notes). Accessed October 16, 2026. https://www.cms.gov/files/zip/2027-code-tables-tabular-index.zip

[3] Centers for Medicare & Medicaid Services. “2027 ICD-10-CM Code Descriptions in Tabular Order” (includes the addenda file listing the October 1, 2026 changes, such as the new Z68.18 and Z68.19). Accessed October 16, 2026. https://www.cms.gov/files/zip/2027-code-descriptions-tabular-order.zip

[4] National Institute of Diabetes and Digestive and Kidney Diseases. “Definition & Facts for Adult Overweight & Obesity.” Accessed October 16, 2026. https://www.niddk.nih.gov/health-information/weight-management/adult-overweight-obesity/definition-facts


Important: This content is for general education and is not medical advice or coding advice. Talk with a licensed provider about your situation. Transformation Health is an independent GLP-1 guide. It does not provide medical care, prescribe, compound, or sell medication, and it does not submit claims or prior authorizations. ICD-10-CM codes on this page are from the FY 2027 code set (effective October 1, 2026); codes are updated each October, so confirm the current code set before use. Coverage determinations depend on your specific plan; check your plan's formulary and prior authorization criteria and talk with your insurer. A licensed provider decides whether a prescription is appropriate. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality, and they are not the same as brand-name products; they may differ in formulation, purity, and potency. Results vary. Transformation Health does not accept payment from providers. How we make money.

FAQ

Frequently Asked Questions

Everything you need to know about getting started.

Still have questions?

Contact our support team
What ICD-10 code is used for obesity?
The ICD-10-CM codes for obesity are in the E66 category. E66.01 is morbid (severe) obesity due to excess calories. E66.09 is other obesity due to excess calories. Since October 2024 the code set also includes obesity class codes (E66.811, E66.812, E66.813). The code titles do not state a BMI range, so they are typically used alongside a BMI documentation code from the Z68 category.
Why does my provider need to include a BMI code?
Insurance prior authorization for GLP-1 weight management often requires documented proof of BMI. The Z68 code series documents the patient's specific BMI range. Including both the obesity diagnosis code (E66.x) and the corresponding BMI code (Z68.3x or higher) in a prior authorization submission gives the insurer the documentation many plans ask for to confirm the patient meets the plan's BMI threshold. Requirements vary by plan.
What comorbidities help support a GLP-1 prior authorization?
Comorbidities commonly documented in GLP-1 prior authorization include hypertension (I10), type 2 diabetes (E11.x), hyperlipidemia (E78.x), obstructive sleep apnea (G47.33), and established cardiovascular disease (I25.x). Including the relevant ICD-10 codes for these conditions alongside obesity codes can support the medical necessity documentation. Each plan sets its own criteria.
What ICD-10 code is used for a GLP-1 weight loss prescription?
GLP-1 prior authorizations for weight management usually use a primary obesity code from the E66 series, often E66.01 (morbid (severe) obesity due to excess calories) or E66.09 (other obesity due to excess calories), or one of the obesity class codes (E66.811 to E66.813), paired with a Z68 code that documents the BMI range. Many payers ask for both. Your provider chooses the codes that match your documented diagnosis.
What is the ICD-10 code for BMI 30 to 39?
The Z68.3x series. Z68.30 covers BMI 30 to 30.9, Z68.31 covers 31 to 31.9, and so on up to Z68.39 for BMI 39 to 39.9. BMI 40 and above in adults uses Z68.41 (40 to 44.9), Z68.42 (45 to 49.9), Z68.43 (50 to 59.9), Z68.44 (60 to 69.9), and Z68.45 (70 or greater).
Do I need ICD-10 codes for a cash-pay GLP-1 program?
Usually not. Codes exist mainly for insurance billing and prior authorization. When you pay out of pocket there is typically no claim to submit, and at most telehealth programs a licensed provider reviews your health history, BMI, and any labs and decides whether a prescription is appropriate. If you plan to seek reimbursement later, ask the program whether it provides an itemized receipt with diagnosis codes.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

About This Site: Disclosures

Who We Are

transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. Providers and programs mentioned on this site are independent third parties.

How We Make Money

Transformation Health does not accept payment from providers.

Educational Purpose

This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Results vary. Trial results describe study participants and are not a prediction for any individual.

Compounded Medications

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy, Ozempic, Zepbound, or Mounjaro. They may differ in formulation, purity, and potency.

Trademarks

Wegovy and Ozempic are trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies.